Erythropoietin (EPO) is a glycosylated cytokine that controls erythroid progenitor survival and differentiation through the erythropoietin receptor (EPOR). The protein backbone and the mature glycoprotein should not be assigned the same molecular mass.
What Are the Key EPO Research Specifications?
| Specification | Research record |
|---|---|
| Compound | EPO |
| Category | misc |
| Listed purity | >99% |
| Molecular weight | ~18.4 kDa backbone; commonly ~30–34 kDa glycosylated |
| Intended use | Laboratory research only |
What Is the Chemical Identity of EPO?
Mature human EPO contains 165 amino acids with three N-linked and one O-linked glycosylation sites. Its polypeptide portion is about 18.4 kDa, while glycosylated EPO typically migrates or measures near 30–34 kDa depending on expression system and glycoform distribution. Sialylation strongly influences charge and clearance. A description of EPO as simply “18 kDa” omits a defining part of the reagent.
Recombinant EPO products can differ in glycan occupancy, sialic-acid content, aggregation and specific activity even when their amino-acid sequences match.
How Does EPO Work in Research Models?
EPO binding promotes EPOR homodimer rearrangement, JAK2 activation and downstream STAT5, PI3K–AKT and MAPK signalling. In erythroid models, useful proximal readouts include EPOR phosphorylation and phospho-STAT5; later outcomes include survival, proliferation and erythroid differentiation. Claimed non-haematopoietic effects require confirmation that the model expresses functional receptor and that observed responses are not caused by contaminants or supraphysiological exposure.
How Should a EPO Study Be Designed?
Report biological activity in calibrated units as well as mass. Include an EPOR-dependent positive-control cell line, receptor blockade or knockout where possible, and a heat-inactivated or vehicle control. When comparing lots or expression systems, normalize by specific activity rather than nominal micrograms alone.
How Should EPO Be Handled and Verified?
EPO is vulnerable to aggregation, surface adsorption and oxidation. Use low-binding consumables, avoid vigorous agitation and repeated freeze-thaw cycles, and qualify the working buffer for recovery at low concentration. Appropriate characterization includes intact mass or glycan profiling, size-exclusion chromatography for aggregates, charge-variant analysis, endotoxin testing and a cell-based potency assay. Reversed-phase HPLC purity alone is inadequate for a glycoprotein.
Which Sources Support EPO Research?
- Elliott et al., structural and functional consequences of EPO glycosylation, Experimental Hematology (2004), DOI: 10.1016/j.exphem.2004.08.011.
- Syed et al., EPOR structure and activation, Nature (1998), DOI: 10.1038/31054.
How Can EPO Results Be Interpreted Without Overclaiming?
Begin interpretation with a falsifiable question and a predeclared primary readout. For EPO, chemical identity, target engagement and downstream phenotype are separate layers. A change in migration, viability or gene expression does not by itself prove the proposed molecular target. Report negative and null findings, not only the largest response. Show individual observations, biological replicates and uncertainty intervals, and identify whether replication means a new well, a new culture, a new animal or a new day.
A citable EPO result states the species, cell line or biochemical system; exact molecular form; concentration and exposure; comparator; assay method; and statistical unit. Confirm that vehicle, pH, osmolality or precipitation did not create the phenotype. Conclusions should stay at the level tested: in vitro activity is not evidence of organism-level efficacy, and an animal phenotype is not a human claim.
Is EPO for Research Use Only?
EPO is supplied for laboratory research only. It is not for human or veterinary use.
Browse Miscellaneous Research Peptides
What Are Common Questions About EPO?
What is EPO?
Erythropoietin (EPO) is a glycosylated cytokine that controls erythroid progenitor survival and differentiation through the erythropoietin receptor (EPOR). The protein backbone and the mature glycoprotein should not be assigned the same molecular mass.
How should researchers verify EPO?
Confirm the exact molecular form on the lot certificate and pair chromatographic purity with an orthogonal identity method such as mass spectrometry or NMR. Use the molecular weight, counterion and content stated for that verified form when calculating molarity.
Is EPO intended for human use?
EPO is listed for controlled laboratory research only. It is not intended for human or veterinary use.